DUBLIN, IRELAND
23 - 25 JUNE 2025
The Content Committee of the World Conference on Tobacco Control 2025 base their programme selection decisions upon the following reviewing process and scoring criteria.
For optimal readability (in mobile and tablet screens) please switch to Landscape mode.
CRITERIA | REQUIREMENTS | SCORING | WEIGHT | |
Scientific abstract | Abstracts on advocacy or policy topics | |||
Background and objectives | The background is relevant and well outlined. The study’s objectives or challenges or working hypotheses are clearly stated. | The policy context and advocacy objectives (where applicable) are clearly described and relevant. | 1 = very poor | 0.5 |
Approach/ Methodology/ Implementation | The study design or intervention is appropriate given the objectives and/or challenges. | Key elements of the advocacy campaign or policy or intervention implementation are clearly described, highlighting relative methods and approaches used. | 1 = very poor | 1 |
Results and/or impact | Results and/or impact are clearly presented and in line with the analysis methodology and objectives. | Results and/or impact are clearly presented in line with the key elements of advocacy approach or policy or intervention implementation. | 1 = very poor | 1 |
Conclusion | The conclusion is clear and consistent with the results. | The conclusion is clear and consistent with results and/or impact. | 1 = very poor | 0.5 |
Relevance | The study/intervention addresses one of the Conference domains, relevant scientific or public health issues. Findings are considered important and are likely to contribute to new knowledge, practice, policies or programmes. | The advocacy campaign or policy or intervention implementation example one of the Conference domains. Findings are considered important and are likely to contribute to new advocacy strategies, knowledge, policies or programmes. | 0 = not relevant | 1 |
Originality and Innovativity | The study and/or findings are new or pathbreaking. | The advocacy or policy or intervention approach is new or path breaking, either in objectives or in strategies to achieve them. | 0 = not original | 1 |
Maximum Score: 25
REVIEWING PROCESS
Each symposium proposal will be reviewed and scored by at least three reviewers. The scores will then be submitted to the members of the Content Committee, who will determine, during a selection meeting, which sessions are accepted.
SCORING
CRITERIA | REQUIREMENTS | SCORING | WEIGHT |
Objectives | Clear and concise session objectives with statements describing what the authors/presenters expect participants to retain from the session. | 1 = very poor | 0.5 |
Coherence | Consistency between individual presentations and the session’s objectives; with a clear theme across presentations. | 1 = very poor | 1 |
Relevance to Conference Priorities | The session addresses and is relevant to the theme of the Conference priorities. | 1 = very poor | 1.5 |
Originality | Session delivering new evidence, approaches, or synthesis of recent information related to the technical area. | 1 = very poor | 1 |
Country representation | This will be pre-populated by the Conference Secretariat. | 0 = only 1 country represented | 1 |
Maximum Score: 22
Dr. Fenton Howell is medical graduate of University College Dublin, Ireland, and completed higher specialist training in Public Health Medicine in 1991. He is the former National Tobacco Control Adviser to the Department of Health, is a Clinical Associate Professor in Public Health in the Department of Public Health and Primary Care at Trinity College Dublin, and is a board member of the National Cancer Registry Ireland. Dr. Fenton Howell is a Fellow of both the Faculty of Public Health Medicine of Ireland and the Royal College of Physicians of Ireland. He is a past Dean of the Faculty of Public Health Medicine of Ireland, and past President of the Royal Academy of Medicine in Ireland, the All Ireland Social Medicine Group and the Irish Medical Organization. He has previously served on the boards of ASH Ireland, the Tobacco Free Research Institute, the European Network on Smoking Prevention, the Institute of Public Health in Ireland and the Medical Bureau of Road Safety, and he chaired the Prevention Working Group for the Ireland–Northern Ireland–United States National Cancer Institute Cancer Consortium.
Dr. Gan Quan, PhD, is Senior Vice President at Vital Strategies, where he leads the Tobacco Control Division, comprising a global team working with governments and civil society partners around the world to reduce tobacco use, the leading preventive cause of deaths worldwide. The Division has supported work in more than 50 low- and middle-income countries with a focus on evidence-based tobacco control policies and implementation, capacity building, and countering interference from the tobacco industry.
Dr. Gan Quan has more than 15 years of international experience in health system building, policy implementation, government partnership, and policy research. Prior to joining Vital Strategies, Dr. Gan Quan spent 14 years with the International Union Against Tuberculosis and Lung Disease (The Union), first as Technical Advisor, then Director of China Office, and most recently as Director of Tobacco Control Department. Before joining The Union, Dr. Gan Quan was a research fellow at the Center for Tobacco Control Research and Education at University of California, San Francisco.
